Associação Médico Espírita de Botucatu Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2014
NCT02683291
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now